Streetbeat News

TSSI

TSS Inc

Employees

Industry

General Warehousing and Storage

Open

11.17

Mkt cap

206M

Volume

1.4M

High

11.35

P/E Ratio

54.00

52-wk high

18.26

Low

8.95

Div yield

N/A

52-wk low

0.43

Cogent Biosciences reports significant symptomatic improvement in non-advanced systemic mastocytosis patients, with a 65% mean improvement in Total Symptom Score (TSS) at 48 weeks. The SUMMIT trial shows promising results, with 88% of patients achieving at least a 50% reduction in TSS. Top-line results are expected by July 2025.

Portfolio Pulse from

February 27, 2025 | 1:15 pm

Topicus.com Inc. has announced a Shareholders' Agreement involving its subsidiaries and the Adam Góral Family Foundation, related to their shareholdings in Asseco Poland S.A. This follows Topicus.com's recent purchase of shares from Cyfrowy Polsat S.A.

Portfolio Pulse from

February 03, 2025 | 12:45 pm

TSS, Inc. (Nasdaq:TSSI), a data center services company, will ring the Nasdaq Closing Bell on January 24, 2025, to commemorate its recent uplisting and achievements.

Portfolio Pulse from

January 23, 2025 | 2:15 pm

TSS, Inc. has secured a $20 million credit facility from Susser Bank to expand operations and enhance power infrastructure, supporting a long-term customer agreement and growing demand for AI technologies.

Portfolio Pulse from

January 07, 2025 | 2:45 pm

TSS, Inc. (Nasdaq:TSSI) has signed a long-term lease for a larger factory space in Georgetown, Texas, to support growing demand for AI-enabled technologies. The new space more than doubles their current capacity and enhances power infrastructure, aligning with a multi-year customer agreement.

Portfolio Pulse from

December 05, 2024 | 9:30 pm

TSSI reported a significant 900% year-over-year earnings increase in Q3, alongside a 689% revenue surge. This growth is attributed to their AI-enabled rack integration and procurement services.

Portfolio Pulse from

November 20, 2024 | 6:45 pm

TSS, Inc. (TSSI) held its Q3 2024 earnings call, discussing financial results and company performance. Key participants included CEO Darryll Dewan and CFO Danny Chism.

Portfolio Pulse from

November 15, 2024 | 3:45 am

TSS, Inc. reported a significant increase in third-quarter revenue and net income, with revenue up 689% to $70.1 million and net income up 1,166% to $2.6 million. The company also signed a multi-year agreement for AI rack integration and is expanding its factory to meet demand for AI technologies. TSS uplisted to the Nasdaq Capital Market.

Portfolio Pulse from

November 14, 2024 | 9:15 pm

Insiders at TSS, Inc., Butler National Corporation, and Fresh Tracks Therapeutics have recently made significant purchases of their companies' shares, indicating potential confidence in their respective companies' futures. These transactions come amidst a backdrop of a rising Dow Jones index and mixed performance among these penny stocks.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 11:09 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.